Blood tests could spot hidden heart risks in aortic stenosis patients

NCT ID NCT06713889

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is collecting blood samples and quality-of-life questionnaires from 125 people with aortic stenosis, a heart valve condition. Researchers want to find biological markers (biomarkers) that could signal inflammation or scarring in the heart before symptoms appear. The goal is to identify which patients might benefit from earlier treatment, like valve replacement. Participants are divided into three groups based on how severe their condition is and whether they need a procedure called TAVI.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify high-risk patients earlier and personalize treatment timing for aortic stenosis.
What could go wrong: This is an observational study, not a treatment trial. It may not find clear biomarkers, and results may not change practice for years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC STENOSIS

Contacts and locations

Locations

Hospices Civils de Lyon - Hôpital Croix Rousse
RECRUITING

Lyon, 69004, France
Hospices Civils de Lyon - Hôpital Louis Pradel
RECRUITING

Lyon, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.